Microscopic testicular sperm extraction in 46,XY differences in sex development caused by 5-alpha reductase type 2 deficiency

被引:0
|
作者
Cardoso, Joao Paulo Greco [1 ]
Nahas, William Carlos [1 ]
Mendonca, Berenice Bilharinho [2 ]
Cocuzza, Marcello Antonio Signorelli [1 ]
机构
[1] Univ Sao Paulo, Hosp Clin, Fac Med, Div Urol, Av Dr Eneas de Carvalho Aguiar 255,7 Andar,Sala 71, BR-05403000 Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Disciplina Endocrinol, Fac Med, Sao Paulo, SP, Brazil
来源
关键词
NONOBSTRUCTIVE AZOOSPERMIA; DIAGNOSIS;
D O I
10.20945/2359-4292-2024-0223
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The 46,XY differences in sex development (DSD) caused by 5-alpha reductase type 2 (5ARD2) often presents with bilateral undescended testicles, otherwise normal internal reproductive structures, prostate hypoplasia and undervirilized male genitalia. Notably, as one of the few DSDs where fertility is possible, the clinical presentation of this disease is diverse, and reported cases of assisted reproduction are scarce. The fertility potential, reproductive counseling and treatment depend on the clinical presentation of this DSD, especially the testicular position and urethral anatomy. The influence of the timing and modality of surgery for hypospadias and cryptorchidism should be considered. We aimed to describe the use of microscopic testicular sperm extraction (micro-TESE) in this population. We provide a descriptive analysis of how micro-TESE is a possible potential tool for assisted reproduction in 5ARD2-deficient patients. A 33-year-old male who underwent bilateral orchidopexy, phalloplasty, and urethroplasty at the age of 9 years presented successful sperm retrieval but failed embryo development after intracytoplasmic sperm injection. Testicular histology revealed late spermatogenic arrest. A 28-year-old male with bilateral orchidopexy, phalloplasty, and urethroplasty at age 25 with unsuccessful sperm retrieval. Testicular histology revealed a Sertoli cell-only pattern. 5ARD2-deficient patients are singular patients. The potential impact of the time between atypical genitalia procedures and orchidopexy on fertility should be highly considered. Micro-TESE is a technique that may be used to assist azoospermic patients in this population. Early orchidopexy and penile and urethral corrections should be considered key strategies to preserve the fertility potential of 5ARD2 patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Differences in testicular development between 5-α-reductase-2 deficiency and isolated bilateral cryptorchidism
    Hadziselimovic, Faruk
    Desouky, Nabil
    HORMONE RESEARCH, 2008, 70 : 214 - 214
  • [22] Male pseudohermaphroditism due to 5-alpha reductase type-2 deficiency in a 20-month old boy
    Andhita, Ida Bagus
    Suryawan, Wayan Bikin
    PAEDIATRICA INDONESIANA, 2006, 46 (9-10) : 236 - 240
  • [23] Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta)
    Prahalada, S
    Tarantal, AF
    Harris, GS
    Ellsworth, KP
    Clarke, AP
    Skiles, GL
    MacKenzie, KI
    Kruk, LF
    Ablin, DS
    Cukierski, MA
    Peter, CP
    vanZwieten, MJ
    Hendrickx, AG
    TERATOLOGY, 1997, 55 (02) : 119 - 131
  • [24] Computer aided screening of inhibitors to 5-alpha reductase type 2 for prostate cancer
    Bhattacharjee, Biplab
    Talambedu, Usha
    Sadegh, Saremy
    Goyal, Arvind Kumar
    Pande, Veena
    Nagaveni, Madhugiri Bhujangarao
    Patil, Vijayakumari Mali
    Jayadev, Joshi
    Middha, Sushil Kumar
    BIOINFORMATION, 2011, 6 (07) : 262 - 265
  • [25] PHENOTYPIC, HORMONAL AND MOLECULAR GENETIC CHARACTERISTICS OF 5-ALPHA REDUCTASE TYPE 2 DEFICIENCY PATIENTS: A MULTICENTER STUDY FROM TURKEY
    Abaci, Ayhan
    Catli, Gonul
    Kirbiyik, Ozgur
    Sahin, Nursel M.
    Abali, Zehra Y.
    Unal, Edip
    Siklar, Zeynep
    Ucakturk, Eda M.
    Ozen, Samim
    Guran, Tulay
    Kara, Cengiz
    Yildiz, Melek
    Eren, Erdal
    Nalbantoglu, Ozlem
    Guven, Ayla
    Cayir, Atilla
    Akbas, Emine D.
    Kor, Yilmaz
    Curek, Yusuf
    Aycan, Zehra
    Bas, Firdevs
    Darcan, Sukran
    Berberoglu, Merih
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 551 - 552
  • [26] Recognition of 5α-reductase-2 deficiency in an adult female 46XY DSD clinic
    Berra, Marta
    Williams, Emma L.
    Muroni, Barbara
    Creighton, Sarah M.
    Honour, John W.
    Rumsby, Gill
    Conway, Gerard S.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (06) : 1019 - 1025
  • [27] 46,XY disorder of sex development (DSD) due to 17β-hydroxysteroid dehydrogenase type 3 deficiency
    Mendonca, Berenice B.
    Gomes, Nathalia Lisboa
    Costa, Elaine M. F.
    Inacio, Marlene
    Martin, Regina M.
    Nishi, Mirian Y.
    Carvalho, Filomena Marino
    Tibor, Francisco Denes
    Domenice, Sorahia
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 165 : 79 - 85
  • [28] Clinical and Laboratorial Features That May Differentiate 46,XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency
    Veiga-Junior, Nelio Neves
    Rodrigues Medaets, Pedro Augusto
    Petroli, Reginaldo Jose
    Calais, Flavia Leme
    de Mello, Maricilda Palandi
    Telles de Sousa Castro, Carla Cristina
    Guaragna-Filho, Guilherme
    Sewaybricker, Leticia Esposito
    Marques-de-Faria, Antonia Paula
    Maciel-Guerra, Andrea Trevas
    Guerra-Junior, Gil
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2012, 2012
  • [29] Gender Change in 46,XY Persons with 5α-Reductase-2 Deficiency and 17β-Hydroxysteroid Dehydrogenase-3 Deficiency
    Peggy T. Cohen-Kettenis
    Archives of Sexual Behavior, 2005, 34 : 399 - 410
  • [30] Gender change in 46,XY persons with 5α-reductase-2 deficiency and 17β-hydroxysteroid dehydrogenase-3 deficiency
    Cohen-Kettenis, PT
    ARCHIVES OF SEXUAL BEHAVIOR, 2005, 34 (04) : 399 - 410